JP Morgan Chase
IMGO

JP Morgan Chase’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

JP Morgan Chase’s Portfolio IMGO Stock Details IMGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,807
Closed -$569K – 7536
2022
Q4 		$569K Sell
15,807
-691
-4% -$17.3K ﹤0.01% 4430
2022
Q3 		$248K Buy
16,498
+976
+6% +$15.8K ﹤0.01% 4850
2022
Q2 		$208K Sell
15,522
-47,205
-75% -$749K ﹤0.01% 5066
2022
Q1 		$1.21M Buy
62,727
+55,964
+828% +$1.16M ﹤0.01% 4133
2021
Q4 		$161K Buy
6,763
+3,029
+81% +$70.2K ﹤0.01% 5468
2021
Q3 		$75K Buy
+3,734
New +$80.1K ﹤0.01% 5712

JP Morgan Chase's IMGO Position: Q1 2023 in Review

JP Morgan Chase sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 15,807 shares — an estimated $569K sold.

JP Morgan Chase first reported a position in IMGO in Q3 2021 and held it in 6 quarters. The position peaked at $1.21M in Q1 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

  • JP Morgan Chase reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
  • JP Morgan Chase sold 15,807 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $569K.
  • JP Morgan Chase first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 6 quarters.
  • JP Morgan Chase's Imago BioSciences, Inc. Common stock position peaked at $1.21M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.